CN113929651B - Method for synthesizing alpha-pyrone compound - Google Patents

Method for synthesizing alpha-pyrone compound Download PDF

Info

Publication number
CN113929651B
CN113929651B CN202111343068.6A CN202111343068A CN113929651B CN 113929651 B CN113929651 B CN 113929651B CN 202111343068 A CN202111343068 A CN 202111343068A CN 113929651 B CN113929651 B CN 113929651B
Authority
CN
China
Prior art keywords
alpha
pyrone compound
pyrone
reaction
synthesizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202111343068.6A
Other languages
Chinese (zh)
Other versions
CN113929651A (en
Inventor
徐四龙
张科强
乔丽娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xi'an Yutebang Pharmaceutical Technology Co ltd
Original Assignee
Xi'an Yutebang Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xi'an Yutebang Pharmaceutical Technology Co ltd filed Critical Xi'an Yutebang Pharmaceutical Technology Co ltd
Priority to CN202111343068.6A priority Critical patent/CN113929651B/en
Publication of CN113929651A publication Critical patent/CN113929651A/en
Application granted granted Critical
Publication of CN113929651B publication Critical patent/CN113929651B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to an alpha-pyrone compound and a synthesis method thereof, wherein the alpha-pyrone compound is generated by catalyzing bromoacetophenone and cyclopropanone to generate [3+3] cyclization reaction under alkaline heating condition through DMAP, and the novel method for efficiently synthesizing the alpha-pyrone compound has the advantages of simple operation, easily available raw materials and potential economic benefit. Because the alpha-pyrone medicine has wide clinical application, the invention provides a novel method for synthesizing the alpha-pyrone compound, which is expected to provide a novel direction for the clinical application of the pyrone. The synthesis method disclosed by the invention is simple to operate, easy to obtain raw materials, mild in reaction conditions, free of metal catalysts, easy to separate and purify products, solves the technical difficulties of complicated steps and complex raw materials of the synthesis method in the prior art, breaks through the prior synthesis technology, and has high application value.

Description

Method for synthesizing alpha-pyrone compound
Technical Field
The invention belongs to the technical field of chemical synthesis, and particularly relates to a synthesis method of an alpha-pyrone compound.
Background
Pyrones are ketone derivatives of pyrans, which are widely found in nature, mainly in plants. Substances such as benzopyran (chromene), chromone, coumarin, flavone, isoflavone, anthocyanin and the like can be considered derivatives of pyrone. The two isomers of the pyrone are divided into alpha-pyrone and gamma-pyrone, wherein the alpha-pyrone is a six-membered cyclic unsaturated lactone, is widely applied to a plurality of natural products, has extremely wide application in the fields of medicines, pesticides, perfumes, dyes and the like, has good biological activity, and is an important intermediate in organic synthesis. The conjugated diene structure of the catalyst is more prone to Diels-Alder reaction.
The synthesis of the alpha-pyrone is a hot spot for research at home and abroad in recent years due to the specificity of the alpha-pyrone structure. The synthesis method of alpha-pyrone reported in the past has the limitations of lengthy steps, complex raw materials, troublesome operation, high temperature conditions, expensive metal catalysts and the like. Based on the method, a new method for synthesizing the alpha-pyrone compound is developed, and the method becomes urgent.
Disclosure of Invention
In order to overcome the defects in the prior art, the invention aims to provide a synthesis method of an alpha-pyrone compound, which is simple to operate, does not need a metal catalyst and has easily available raw materials.
In order to achieve the above purpose, the invention is realized by adopting the following technical scheme:
the invention discloses a synthesis method of an alpha-pyrone compound, which comprises the steps of catalyzing bromoacetophenone and cyclopropanone to generate [3+3] cyclization reaction under alkaline heating condition through 4-dimethylaminopyridine to synthesize the alpha-pyrone compound, wherein:
the bromoacetophenone has the following structural formula:
Figure GDA0003408519410000021
the structural formula of the cyclopropenone is as follows:
Figure GDA0003408519410000022
the structural formula of the synthesized alpha-pyrone compound is as follows:
Figure GDA0003408519410000023
wherein R is 1 ,R 2 ,R 3 The group is an alkyl or aryl group.
Preferably, the synthesis method of the alpha-pyrone compound comprises the following steps:
1) Adding bromoacetophenone and cyclopropenone into an alkaline organic solvent under the protection of nitrogen, and stirring for 8-14 h under the heating condition under the catalysis of 4-dimethylaminopyridine, and cooling to room temperature after the reaction is finished;
2) Filtering, concentrating and purifying the reaction system by column chromatography to obtain the alpha-pyrone compound.
It is further preferable that the reaction molar ratio of cyclopropenone, bromoacetophenone and 4-dimethylaminopyridine is 1.0 (1.0-1.5): 1.0-1.5.
Further preferably, the reaction charge ratio of cyclopropenone to organic solvent is 0.2mmol (1-2) mL.
Further preferably, the organic solvent is 1, 4-dioxane, which is made basic by the addition of potassium hydroxide.
Further preferably, the heating temperature is 50 to 65 ℃.
Still more preferably, the heating temperature is 60 ℃.
Further preferably, in step 1), column chromatography is performed using a silica gel column chromatography using petroleum ether: ethyl acetate = 20: purifying by passing the mixture through a column according to the volume ratio of 1.
Compared with the prior art, the invention has the following beneficial effects:
the invention discloses a synthesis method of an alpha-pyrone compound, which is characterized in that bromoacetophenone and cyclopropanone are subjected to [3+3] cyclization reaction under the condition of DMAP catalysis and alkaline heating to obtain the alpha-pyrone compound. In the synthesis method, the cyclopropenone and bromoacetophenone which are used as reaction raw materials are conveniently obtained, so that the problem of complex raw material sources in the prior art is solved; the target product is obtained by the cyclization reaction of [3+3] under the alkaline heating condition, the reaction condition is consistent and is not required to be adjusted, and the metal catalyst is not required to be added into the reaction system, so that impurities such as metal and the like can not be introduced into the system on the one hand, and the separation and purification processes of the product are simple on the other hand, so that the synthesis method is a synthesis method which is simple to operate and mild in reaction condition.
Furthermore, in the synthesis method provided by the invention, the reaction is carried out at 60 ℃, so that the high conversion rate of the alpha-pyrone compound can be ensured, and the operation convenience and safety can be ensured.
Drawings
FIG. 1 is a diagram showing the mechanism of the synthesis reaction of the α -pyrone compound of the present invention.
Detailed Description
In order that those skilled in the art will better understand the present invention, a technical solution in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in which it is apparent that the described embodiments are only some embodiments of the present invention, not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the present invention without making any inventive effort, shall fall within the scope of the present invention.
It should be noted that the terms "comprises" and "comprising," along with any variations thereof, in the description and claims of the present invention are intended to cover a non-exclusive inclusion, such as a process, method, system, article, or apparatus that comprises a list of steps or elements is not necessarily limited to those steps or elements expressly listed or inherent to such process, method, article, or apparatus, but may include other steps or elements not expressly listed or inherent to such process, method, article, or apparatus.
The invention is described in further detail below with reference to the attached drawing figures:
the invention discloses a synthesis method of an alpha-pyrone compound, which comprises the step of catalyzing bromoacetophenone and cyclopropanone to generate [3+3] cyclization reaction under alkaline heating condition through DMAP to generate the alpha-pyrone compound.
The mechanism of the [3+3] cyclization reaction is that bromoacetophenone and DMAP react to generate an intermediate A, KOH is removed from hydrogen at a carbonyl alpha-position to generate a nitrogenous ylide B, the intermediate B and the intermediate C are tautomerized, an intermediate D is generated by attacking the side of cyclopropenone with smaller steric hindrance, and the ketene structure E generated by leaving DMAP is subjected to the [3+3] cyclization reaction to generate the final product alpha-pyrone. The reaction mechanism is shown in FIG. 1.
Bromoacetophenone and cyclopropenone occur under alkaline heating conditions, and the reaction formula is as follows:
Figure GDA0003408519410000041
r in the above reaction formula 1 ,R 2 ,R 3 The group is alkyl and aryl;
the method comprises the following steps: adding bromoacetophenone and cyclopropenone into an alkaline organic solvent under the protection of nitrogen, and stirring for 12 hours under the catalysis of DMAP under the heating condition; after the reaction is finished, cooling to room temperature; filtering, rotary evaporation concentration and column chromatography to obtain alpha-pyrone compounds;
preferably, the ratio of cyclopropenone A to bromoacetophenone B in the process of the present invention is 1:1.5; the solvent adopted in the invention is 1, 4-dioxane; the molar ratio of the cyclopropenone A to the 1, 4-dioxane is as follows: 0.2 mmol/1-2 mL; the temperature adopted by the heating is 60 ℃;
example 1
Diphenylcyclopropenone (0.2 mmol), 2-bromo-1-4- (trifluoromethoxy) phenylethanone (0.3 mmol), DMAP (20 mol%), KOH (0.3 mmol) were added to 100mg of 4A molecular sieve (for the purpose of water removal, the reaction was controlled to proceed under anhydrous conditions) and 1, 4-dioxane (2.0 mL) under nitrogen, heated at 60℃for 12h, cooled to room temperature after completion of the reaction, filtered and concentrated by vacuum distillation and purified by flash column chromatography (silica gel, petroleum ether/ethyl acetate mixture, 20:1, v/v) to afford the desired pure product 67.3mg in 82% yield as a yellow solid with a melting point of 134-136 ℃. The structural formula is as follows:
Figure GDA0003408519410000042
1 H NMR(400MHz,CDCl 3 )(δ,ppm):7.93(d,J=8.9Hz,2H,Ar-H),7.38–7.13(m,13H,Ar-H),6.82(s,1H,Ar-H).
13 C{1H}NMR(400MHz,CDCl 3 ;δ,ppm):162.4,156.7,152.5,150.7,137.5,133.5,130.8,129.8,128.8,128.6,128.4,128.0,127.8,127.2,123.5,121.1,105.4.
IRν max (neat):1697,1504,1266,1210,1150,833,,789,769,699cm -1 .
HRMS(ESI)calcd for C 24 H 15 F 3 O 3 [M+H]+:409.1046,found:409.1048.
example 2
The procedure described in example 1 was followed, except that the substrates used were: diphenylcyclopropenone (0.2 mmol), 2-bromo-1-4- (trifluoromethyl) phenylethanone (0.3 mmol), DMAP (20 mol%), KOH (0.3 mmol), 100mg of 4A molecular sieve and 1, 4-dioxane (2.0 mL) gave 59.5mg of product in 76% yield as a yellow solid with a melting point of 170-172 ℃. The structural formula is as follows:
Figure GDA0003408519410000051
1 H NMR(400MHz,CDCl 3 )(δ,ppm):8.03(d,J=8.2Hz,2H,Ar-H),7.74(d,J=8.3Hz,2H,Ar-H),7.32–7.15(m,10H,Ar-H),6.93(s,1H,Ar-H).
13 C{1H}NMR(400MHz,CDCl 3 ;δ,ppm):162.2,156.3,152.2,137.3,134.5,133.4,130.7,128.9,128.6,128.4,1278.0 128.0,126.0,125.9,125.7,124.3,106.3.
IRν max (neat):1697,1537,1329,1160,1117,1072,831,789,699cm -1 .
HRMS(ESI)calcd for C 24 H 15 F 3 O 2 [M+H]+:393.1097,found:393.1100
example 3
The procedure described in example 1 was followed, except that the substrates used were: diphenylcyclopropenone (0.2 mmol), 2-bromo-1-cyclohexylethanone (0.3 mmol), DMAP (20 mol%), KOH (0.3 mmol), heating to 65℃and 100mg of 4A molecular sieve and 1, 4-dioxane (2.0 mL) gave 27.8mg of the product as a white solid with a yield of 42% and a melting point of 124-125 ℃. The structural formula is as follows:
Figure GDA0003408519410000052
1 H NMR(400MHz,CDCl 3 )(δ,ppm):7.25–7.07(m,10H,Ar-H),6.13(s,1H,Ar-H),2.49(t,J=11.6Hz,1H,CH),2.07(d,J=13.2Hz,2H,CH 2 ),1.86(d,J=12.9Hz,2H,CH 2 ),1.75(d,J=15.2Hz,1H,CH 2 ),1.57–1.18(m,5H,CH 2 ).
13 C{1H}NMR(400MHz,CDCl 3 ;δ,ppm):167.89,163.63,152.84,137.97,134.10,130.93,128.77,128.64,128.32,128.02,127.57,122.18,104.50,42.32,30.65,25.87.
IRν max (neat):2929,2853,1699,1634,1538,944,764,606,564cm -1 .
HRMS(ESI)calcd for C 23 H 22 O 2 [M+H]+:331.1693,found:331.1690.
example 4
The procedure described in example 1 was followed, except that the substrates used were: 2-butyl-3-phenylcyclopropanone (0.2 mmol), bromoacetophenone (0.3 mmol), DMAP (20 mol%), KOH (0.3 mmol), 100mg of 4A molecular sieve and 1, 4-dioxane (2.0 mL) were heated to 55℃to give 26.8mg of the product as a yellow solid in 44% yield with a melting point of 92-94 ℃. The structural formula is as follows:
Figure GDA0003408519410000061
1 H NMR(400MHz,CDCl 3 )(δ,ppm):7.90–7.86(m,2H,Ar-H),7.49–7.41(m,5H,Ar-H),7.38(m,1H,Ar-H),7.31–7.28(m,2H,Ar-H),6.67(m=s,1H,Ar-H),2.39(m 2H,CH 2 ),1.51-1.55(m,2H,CH2),1.31–1.24(m,2H,CH 2 ),0.83(t,J=7.3Hz,3H,CH 3 ).
13 C{1H}NMR(400MHz,CDCl 3 ;δ,ppm):162.65,158.22,155.66,134.13,131.60,130.61,130.02,128.96,128.48,128.05,125.61,124.33,103.89,33.11,31.41,22.53,13.80.
IRν max (neat):2962,2927,1706,1627,1538,1451,1351,722,692cm -1 .
HRMS(ESI)calcd for C 21 H 20 O 2 [M+H]+:305.1536,found:305.1537
example 5
The procedure described in example 1 was followed, except that the substrates used were: bis- (4-methylphenyl) cyclopropenone (0.2 mmol), bromoacetophenone (0.3 mmol), DMAP (20 mol%), KOH (0.3 mmol), heating to 50℃and 100mg of 4A molecular sieve and 1, 4-dioxane (2.0 mL) gave 26.2mg of the product as a yellow solid in 50% yield with a melting point of 174-176 ℃. The structural formula is as follows:
Figure GDA0003408519410000071
1H NMR(400MHz,CDCl3)(δ,ppm):7.88(d,J=9.7Hz,2H,Ar-H),7.63(d,J=8.2Hz,2H,Ar-H),7.56(d,J=7.2Hz,1H,Ar-H),7.47(d,J=7.1Hz,3H,Ar-H),7.25(d,J=9.4Hz,2H,Ar-H),6.78(d,J=7.2Hz,1H,Ar-H),2.39(s,3H,CH3).
13C{1H}NMR(400MHz,CDCl3;δ,ppm):161.61,159.57,139.75,138.61,131.95,131.35,130.71,129.25,129.02,128.08,125.81,125.53,101.85,21.36.
IRνmax(neat):1711,1622,1556,1495,1115,902,823,762,685cm-1.
HRMS(ESI)calcd for C18H14O2[M+H]+:263.1067,found:263.1066.
example 6
The procedure described in example 1 was followed, except that the substrates used were: 2-3-bis (4-methylphenyl) cyclopropenone (0.2 mmol), bromoacetophenone (0.3 mmol), DMAP (20 mol%), KOH (0.3 mmol), 100mg of 4A molecular sieve and 1, 4-dioxane (2.0 mL) gave 42.2mg of product in 59% yield as a yellow solid with a melting point of 158-160 ℃. The structural formula is as follows:
Figure GDA0003408519410000072
1 H NMR(400MHz,CDCl 3 )(δ,ppm):7.90(m,2H,Ar-H),7.51–7.44(m,3H,Ar-H),7.08(d,J=6.6Hz,8H,Ar-H),6.82(s,1H,Ar-H),2.32(d,J=6.2Hz,6H,CH 3 ).
13 C{1H}NMR(400MHz,CDCl 3 ;δ,ppm):163.05,157.94,152.35,138.84,137.46,135.07,131.60,131.07,130.77,130.67,129.17,128.99,128.86,128.75,125.63,122.94,105.21,21.41.
IRν max (neat):1701,1625,1531,1350,979,815,726,690,646cm -1 .
HRMS(ESI)calcd for C 25 H 20 O 2 [M+H]+:353.1536,found:353.1536.
example 7
The procedure described in example 1 was followed, except that the substrates used were: 2-3-bis (4-fluorophenyl) cyclopropanone (0.2 mmol), bromoacetophenone (0.3 mmol), DMAP (20 mol%), KOH (0.3 mmol), 100mg of 4A molecular sieve and 1, 4-dioxane (2.0 mL) give 64.1mg of the product in 89% yield as a yellow solid with a melting point of 204-206 ℃. The structural formula is as follows:
Figure GDA0003408519410000081
1 H NMR(400MHz,CDCl 3 )(δ,ppm):7.93–7.88(m,2H,Ar-H),7.51–7.46(m,3H,Ar-H),7.20–7.12(m,4H,Ar-H),7.01–6.92(m,4H,Ar-H),6.80(s,1H,Ar-H).
13 C{1H}NMR(400MHz,CDCl 3 ;δ,ppm):164.09,164.05,163.51,162.61,161.60,161.04,158.66,151.96,133.67,133.63,132.80,132.72,131.23,131.06,130.78,130.69,129.62,129.58,129.11,125.72,122.16,115.93,115.72,115.46,115.24,104.76.
IRν max (neat):1687,1536,1351,1223,1157,842,762,557,543cm -1 .
HRMS(ESI)calcd for C 23 H 14 F 2 O 2 [M+H]+:361.1035,found:361.1037.
the above is only for illustrating the technical idea of the present invention, and the protection scope of the present invention is not limited by this, and any modification made on the basis of the technical scheme according to the technical idea of the present invention falls within the protection scope of the claims of the present invention.

Claims (5)

1. The synthesis method of the alpha-pyrone compound is characterized in that 4-dimethylaminopyridine catalyzes alpha-bromoketone and substituted cyclopropanone to perform [3+3] cyclization reaction under alkaline heating condition to synthesize the alpha-pyrone compound, wherein:
the structural formula of the alpha-bromoketone is as follows:
Figure FDA0004262208750000011
the structural formula of the substituted cyclopropenone is as follows:
Figure FDA0004262208750000012
the structural formula of the synthesized alpha-pyrone compound is as follows:
Figure FDA0004262208750000013
wherein R is 1 ,R 2 ,R 3 The group is alkyl or aryl;
the method specifically comprises the following steps:
1) Under the protection of nitrogen, adding alpha-bromoketone and substituted cyclopropanone into an alkaline organic solvent, and under the heating condition, carrying out catalytic stirring on 4-dimethylaminopyridine for 8-14 h, and cooling to room temperature after the reaction is finished; wherein:
the heating temperature is 50-65 ℃;
the organic solvent is 1, 4-dioxane, and is adjusted to be alkaline by adding potassium hydroxide;
2) Filtering, concentrating and purifying the reaction system by column chromatography to obtain the alpha-pyrone compound.
2. The method for synthesizing an alpha-pyrone compound according to claim 1, wherein the reaction molar ratio of the substituted cyclopropenone, the alpha-bromoketone and the 4-dimethylaminopyridine is 1.0:1.0-1.5.
3. The method for synthesizing an α -pyrone compound according to claim 1, wherein the reaction charge ratio of the substituted cyclopropenones to the organic solvent is 0.2mmol (1-2) mL.
4. The method for synthesizing an α -pyrone compound according to claim 1, wherein the heating temperature is 60 ℃.
5. The method for synthesizing an α -pyrone compound according to claim 1, wherein in step 1), column chromatography is performed using a silica gel column using petroleum ether: ethyl acetate = 20: purifying by passing the mixture through a column according to the volume ratio of 1.
CN202111343068.6A 2021-11-12 2021-11-12 Method for synthesizing alpha-pyrone compound Active CN113929651B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111343068.6A CN113929651B (en) 2021-11-12 2021-11-12 Method for synthesizing alpha-pyrone compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111343068.6A CN113929651B (en) 2021-11-12 2021-11-12 Method for synthesizing alpha-pyrone compound

Publications (2)

Publication Number Publication Date
CN113929651A CN113929651A (en) 2022-01-14
CN113929651B true CN113929651B (en) 2023-07-07

Family

ID=79286661

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111343068.6A Active CN113929651B (en) 2021-11-12 2021-11-12 Method for synthesizing alpha-pyrone compound

Country Status (1)

Country Link
CN (1) CN113929651B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113150006A (en) * 2021-02-02 2021-07-23 五邑大学 Pyran compound and synthetic method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4734606B2 (en) * 2006-05-08 2011-07-27 国立大学法人大阪大学 Organic element containing α-pyrone and / or α-pyrone derivative
CN113214204B (en) * 2021-05-13 2022-05-17 河南师范大学 Synthesis method of 2-pyrone compound and alpha, beta-unsaturated chain ester compound

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113150006A (en) * 2021-02-02 2021-07-23 五邑大学 Pyran compound and synthetic method thereof

Also Published As

Publication number Publication date
CN113929651A (en) 2022-01-14

Similar Documents

Publication Publication Date Title
Deng et al. A practical, highly enantioselective synthesis of the taxol side chain via asymmetric catalysis.
CN100564370C (en) The preparation of isoflavone derivative
CN112608296B (en) Synthesis method of Brazilane natural product Brazilane
CN112574163A (en) Method for synthesizing Brazilin natural product (+) -Brazilin
CN113861137B (en) Method for synthesizing furan compound by one-step reaction of ketone and alpha chloroketone
CN107032972B (en) Preparation method of Diels-Alder product with 2' -hydroxychalcone structure
CN106946823B (en) Method for asymmetric synthesis of (R) -natural jasminolide
CN113929651B (en) Method for synthesizing alpha-pyrone compound
CN111454230B (en) Synthesis method of key intermediate Tuv of natural anticancer drug Tubulysins
Gypser et al. D-Erythronolactone as a C 4 building unit. Part 2.1 A short and efficient synthesis of both enantiomers of epi-muricatacin, a diastereoisomer of the native acetogenin from Annona muricata
CN113717132B (en) Key intermediate of antiepileptic drug and preparation method thereof
CN106316813B (en) 3-substituted 3-vinyl-2-hydroxy-1-aryl acetone and synthesis method thereof
CN111995605B (en) Chrysin cinnamate or its derivative and its preparation method
CN110092751B (en) Synthesis method of 2-alkyl quinoline
Bonacorso et al. Efficient entry to trifluoromethyl substituted chromanes from oxidative aromatization of tetrahydro-2H-chromen-5 (6H)-ones using iodine/alcohol with conventional and microwave methods
CN107501159B (en) Synthesis method of vilazodone intermediate 3- (4-chlorobutyl) -5-cyanoindole
CN116023357B (en) Method for converting o-hydroxyacetophenone into quaternary carbon center-containing chromanone compound
CN109384753B (en) Synthetic method of 2-phenyl-3-methylbenzofuran compound
CN111662318B (en) Iloprost key intermediate and preparation method thereof
CN115850216B (en) Stable isotope labeled 2, 5-furandicarboxylic acid-2-13Method for synthesizing COOH
CN112142709B (en) Synthetic method of 6-aryl-2,3,4,5-tetrahydrooxaheptin-3-alcohol derivative
CN113264972B (en) Method for preparing obeticholic acid
CN115010717B (en) Full-synthesis preparation method of lycorine (+ -) -alpha-lycorane
JP4598917B2 (en) Method for producing lactone
CN113943220B (en) Photochemical synthesis method of 1, 4-dicarbonyl compound derivative

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant